Targeting mutation may offer way of treating triple-negative breast cancer
from Breast Cancer News
Researchers in Ireland may have found a promising treatment for patients with triple-negative breast cancer, the most aggressive form of breast cancer. Their study, "Mutant p53: A novel target for the treatment of patients with triple-negative breast cancer?," published in the International Journal of Cancer, shows that a drug which targets the p53 mutated protein can largely inhibit triple-negative breast cancer cell proliferation and migration, while also promoting programmed cell death.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063